top of page

We are pioneers in zinc research for brain injury and neurodegenerative disease.

Company Overview

  • Established: March 2020

  • Current Investment: $1.5 M USD from Venture Capitals

  • ​Research Focus

    • Acute Ischemic Brain Injury

    • Neurodegenerative Brain Disease

  • Government-Funded Research Projects

    1. TIPS​(Tech Incubator Program for Startup)

      • Research Area: Multiple Sclerosis (Lead compound)

      • Grant $0.4M USD

      • Duration: July 2021~ June 2023

    2. KDDF​(Korea Drug Development Fund)

      • Research Area: Amyotrophic Lateral Sclerosis(Preclinical candidate)​

      • Grant: $1M USD

      • Duration: April 2023 - March 2025

  • Collaborations

    • Asan Medical Center

    • Hallym University

    • Harvard Medical School

bottom of page